Evolent Health A Aktie
2,30
EUR
+0,04
EUR
+1,77
%
2,79
USD
+0,06
USD
+2,01
%
Werbung
Evolent Health A Aktie Analyse
| 01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
| 13.07.16 | Evolent Health A Outperform | FBR Capital | |
| 29.03.16 | Evolent Health A Outperform | FBR Capital | |
| 06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung